---
name: Exception - Biopsy After Treatment

externalData:
- resources

data:
- 
  resourceType: Patient
  name: Joanne Smith
  gender: female
  birthDate: 1991-01-01
  extension:
  -
    url: http://hl7.org/fhir/us/core/StructureDefinition/us-core-birthsex
    valueCode: F
-
  $iterate: *Cin2orCin3LastYear
-
  $import: *CervicalPrecancerTreatmentLastYear
- 
  resourceType: DiagnosticReport
  code: LOINC#21440-3 Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe
  status: final
  conclusionCode:
  - SNOMEDCT#720005005 Human papillomavirus deoxyribonucleic acid test positive, high risk on cervical specimen (finding)
  effectiveDateTime: 2021-05-01
- 
  resourceType: DiagnosticReport
  code: LOINC#10524-7 Microscopic observation [Identifier] in Cervix by Cyto stain
  status: final
  conclusionCode:
  - SNOMEDCT#62051000119105 Low grade squamous intraepithelial lesion on cervical Papanicolaou smear (finding)
  effectiveDateTime: 2021-05-01

# Risk Table 5 recommends a colposcopy after an HPV-positive/LSIL result following a treatement
- 
  resourceType: DiagnosticReport
  code: LOINC#65753-6 Cervix Pathology biopsy report
  status: final
  conclusionCode:
  - SNOMEDCT#285836003 Cervical intraepithelial neoplasia grade 1 (disorder)
  effectiveDateTime: 2021-05-20

results:
  # This patient is no longer being managed by Risk Table 5, since they have had a follow-on biopsy after their treatment
  Recommendation:
    short: 'Surveillance 1-year follow-up'
    date: '2022-05-20'
    group: 'Colposcopy Results (Table 3)'
    details:
    - 'Primary HPV testing or cotesting is recommended in 1 year from date of most recent test.'
    - 'If HPV testing or cotesting is not available, Pap testing may be performed. This is recommended at 6-month intervals from date of most recent test.'
  WhichTableMadeTheRecommendation: 3